TERT-BUTYL (4S)-2-(4-FLUORO-3,5-DIMETHYLPHENYL)-3-((4R)-4-HYDROXY-2-OXOIMIDAZOLIDIN-1-YL)-4-METHYL-6,7-DIHYDRO-4H-PYRAZOLO(4,3-C)PYRIDINE-5-CARBOXYLATE
UNII GJ6RKL5FYJ
Substance Identification & Data
This profile provides standardized clinical and technical data for Tert-butyl (4s)-2-(4-fluoro-3,5-dimethylphenyl)-3-((4r)-4-hydroxy-2-oxoimidazolidin-1-yl)-4-methyl-6,7-dihydro-4h-pyrazolo(4,3-c)pyridine-5-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GJ6RKL5FYJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H30FN5O4 HQIMHLPAXAITJO-WMLDXEAASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tert-butyl (4s)-2-(4-fluoro-3,5-dimethylphenyl)-3-((4r)-4-hydroxy-2-oxoimidazolidin-1-yl)-4-methyl-6,7-dihydro-4h-pyrazolo(4,3-c)pyridine-5-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.